Literature summary extracted from
Naidu, P.S.; Kinsey, S.G.; Guo, T.L.; Cravatt, B.F.; Lichtman, A.H.
Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase (2010), J. Pharmacol. Exp. Ther., 334, 182-190.
Application
EC Number |
Application |
Comment |
Organism |
---|
3.5.1.99 |
drug development |
FAAH is an attractive target for treating pain |
Mus musculus |
Inhibitors
EC Number |
Inhibitors |
Comment |
Organism |
Structure |
---|
3.5.1.99 |
cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester |
i.e. URB597, attenuates the development of lipopolysaccharide-induced paw edema and reverses lipopolysaccharide-induced hyperalgesia through the respective CB2 and CB1 mechanisms of action. The inhibition is not affected by capsazepine, a transient receptor potential vanilloid type 1 antagonist |
Mus musculus |
|
Natural Substrates/ Products (Substrates)
EC Number |
Natural Substrates |
Organism |
Comment (Nat. Sub.) |
Natural Products |
Comment (Nat. Pro.) |
Rev. |
Reac. |
---|
3.5.1.99 |
anandamide + H2O |
Mus musculus |
i.e. N-arachidonoylethanolamine |
arachidonic acid + ethanolamine |
- |
? |
|
Organism
EC Number |
Organism |
UniProt |
Comment |
Textmining |
---|
3.5.1.99 |
Mus musculus |
- |
male C57BL/6J mice |
- |
Source Tissue
EC Number |
Source Tissue |
Comment |
Organism |
Textmining |
---|
3.5.1.99 |
neuron |
- |
Mus musculus |
- |
Substrates and Products (Substrate)
EC Number |
Substrates |
Comment Substrates |
Organism |
Products |
Comment (Products) |
Rev. |
Reac. |
---|
3.5.1.99 |
anandamide + H2O |
i.e. N-arachidonoylethanolamine |
Mus musculus |
arachidonic acid + ethanolamine |
- |
? |
|
Synonyms
EC Number |
Synonyms |
Comment |
Organism |
---|
3.5.1.99 |
FAAH |
- |
Mus musculus |
General Information
EC Number |
General Information |
Comment |
Organism |
---|
3.5.1.99 |
physiological function |
FAAH is the chief catabolic enzyme regulating the endogenous cannabinoid N-arachidonoylethanolamine, i.e. anandamide |
Mus musculus |